Dellon Evan S, Hirano Ikuo
Center for Esophageal Diseases and Swallowing and Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Divsion of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Gastroenterology. 2018 Jan;154(2):319-332.e3. doi: 10.1053/j.gastro.2017.06.067. Epub 2017 Aug 1.
Eosinophilic esophagitis (EoE) has emerged over the past 2 decades as a major cause of upper gastrointestinal morbidity. Over this time, the epidemiology of EoE has also rapidly evolved. EoE has transformed from a rare case-reportable condition to disease that is commonly encountered in the gastroenterology clinic, hospital emergency room, and endoscopy suite. The incidence and prevalence are increasing at rates that outpace increased disease recognition. Current incidence estimates range from 5 to 10 cases per 100,000, and current prevalence estimates range from 0.5 to 1 case per 1000. We review the data and potential reasons behind this increase, examine risk factors, and identify important areas for research into disease etiology. The article also discusses the progression of EoE from an inflammatory to fibrostenotic phenotype. An accurate view of the natural history of EoE is central to discussions with patients regarding disease prognosis and decisions about long-term use of medical, endoscopic, and diet therapies. Progressive remodelling appears to be gradual, but not universal, and the duration of untreated disease is the best predictor of stricture risk. Ultimately, prospective, long-term outcome studies focusing on multiple aspects of disease activity are needed to fully understand the natural history of EoE.
嗜酸性粒细胞性食管炎(EoE)在过去20年中已成为上消化道发病的主要原因。在此期间,EoE的流行病学也迅速演变。EoE已从一种罕见的可报告病例疾病转变为在胃肠病诊所、医院急诊室和内镜检查室中常见的疾病。其发病率和患病率的增长速度超过了疾病认知度的提高。目前的发病率估计为每10万人中有5至10例,目前的患病率估计为每1000人中有0.5至1例。我们回顾了这种增长背后的数据和潜在原因,研究了危险因素,并确定了疾病病因研究的重要领域。本文还讨论了EoE从炎症表型到纤维狭窄表型的进展。准确了解EoE的自然史对于与患者讨论疾病预后以及决定长期使用药物、内镜和饮食疗法至关重要。渐进性重塑似乎是渐进的,但并非普遍存在,未治疗疾病的持续时间是狭窄风险的最佳预测指标。最终,需要进行关注疾病活动多个方面的前瞻性长期结局研究,以充分了解EoE的自然史。